Business Wire5h
Fresenius Continues Growth of Biosimilars Portfolio with the U.S. Availability of Otulfi ® (ustekinumab-aauz)
Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality ...
Frontiers19h
Molecular mechanisms and clinical studies of multi-organ dysfunction in sepsis associated with pathogenic microbial infection
This research topic aims to delve into the pathophysiological mechanisms underlying sepsis-associated organ dysfunctions, including sleep disturbances, encephalopathy, ARDS, kidney injury, and ...